Sheba Launches New Pilot Program to Help Those with Severe Allergies get Safely Vaccinated
January 25, 2021
200 Israelis with severe allergies were vaccinated for the first time at Sheba as part of a critical pilot program. Individuals with severe allergies are otherwise currently turned away from health clinics due to concerns of severe reactions to the COVID-19 vaccine. If successful, the hospital will share its findings with other medical centers and health funds, potentially expanding the program to the public. Prof. Nancy Agmon-Levin, head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic at Sheba, recently discussed this program with the Jerusalem Post.